Searched for
ASTRAZENECA UK
UK's FTSE 100 slips as losses in energy stocks and AstraZeneca weighLondon’s FTSE 100 edged lower as losses in energy majors and AstraZeneca weighed on the index amid thin holiday trading. Weak crude prices ...- AstraZeneca plans to invest $405 million in Britain, PM Keir Starmer saysPrime Minister Keir Starmer announced AstraZeneca will invest 300 million pounds in UK life sciences. This significant investment secures 1...
- AstraZeneca India plans to sell 64-acre Bengaluru site for Rs 3,400 croreThe land parcel, expected to fetch about ₹3,400 crore for AstraZeneca Pharma India, has drawn interest from developers including the Sattva...
- AstraZeneca gets $107 mln Pfizer verdict overturned in US cancer drug patent fightOn Wednesday, U.S. District Judge Matthew Kennelly invalidated Pfizer’s patents related to the cancer drug Nerlynx, overturning a jury's $1...
- AstraZeneca Pharma India plans to sell Bengaluru plantThe company will position the manufacturing site for sale in a fully operational manner and begin a search for a buyer who can also act as ...
- AstraZeneca Covid booster shot effective against severe disease, UK study findsThe researchers from the UK Health Security Agency, London, estimated vaccine effectiveness by analysing data on all adults aged 18 years a...
- AstraZeneca delivers 68 million doses of COVID-19 vaccine in first quarterThe Anglo-Swedish drugmaker on Friday reported $275 million in revenue from sales of the vaccine, or the equivalent of $4.04 per dose. Astr...
- EU agency says people should get second dose of AstraZeneca tooThe agency said there were "no or limited data to change current recommendations." It said it wasn't known whether the risk of a rare blood...
- Covid vaccine: Why is AstraZeneca making so many unforced errors?The has been communication of scientific results. November data from trials in the U.K. and Brazil generated confusion over efficacy. This ...
- SII seeks Government's nod to give 50 lakh Covishield doses to UK, says won't affect India's vaccination driveIn a communique to Union Health Secretary Rajesh Bhushan on Tuesday, the Director of Government and Regulatory Affairs at the Pune-based Se...
- UK to receive 10 million AstraZeneca doses from Serum InstituteSII, the world’s largest vaccine manufacturer by volume, is mass producing the AstraZeneca vaccine, developed with Oxford University, for d...
- UK plant producing AstraZeneca vaccines partially evacuated over suspect packageWockhardt UK provides fill-and-finish capacity for AstraZeneca's UK supply chain, which is the final manufacturing step of putting vaccines...
- AstraZeneca sells cholesterol drug rights to Grünenthal for $320 millionAstraZeneca, which is among the front-runners in the race to develop a vaccine for the novel coronavirus, has been trying to focus on its c...
- Oxford, AstraZeneca COVID-19 vaccine trials resume days after pauseThe study had been previously stopped in July for several days after a participant who got the vaccine developed neurological symptoms; it ...
- India trials of COVID-19 vaccine is going on: Serum InstituteLast month, the Drug Controller General of India had granted permission to the Pune-based SII to conduct Phase-II and -III human clinical t...
- AstraZeneca gets extension for Meronem withdrawal till August 31The product is currently one of the company's principal products which generated 18 per cent total turnover of the firm in fiscal ended Mar...
- AstraZeneca inaugurates global technology centre in ChennaiThe company is also looking to develop additional technology centres with a second GTC planned for San Francisco in 2015.
- AstraZeneca rejects 55 pounds/share Pfizer offerBritain's AstraZeneca on Monday rejected a sweetened 55-pounds-a-share offer from Pfizer.
- AstraZeneca planning to delist Indian subsidiary; likely to appoint Merrill Lynch as manager for delistingAstraZeneca, the world's seventh largest drug maker by sales, is planning to delist its Indian subsidiary, said two people with knowledge o...
- AstraZeneca Pharma NCDs get P1 ratingCRISIL has assigned ‘P1+’ rating to the short term secured fully-paid redeemable non-convertible bonus debenture issue of AstraZeneca Pharm...
Load More
